Bajaj Finserv Healthcare Fund - Direct - Growth
Bajaj Finserv Asset Management Limited · Direct Plan · Growth
Fund overview
1% on or before 3M, Nil after 3M
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,062 | +62 |
| 3 Years | ₹1,000 | ₹1,198 | +198 |
| 5 Years | ₹1,000 | ₹1,351 | +351 |
Calculated using the fund's annualised return since inception (6.2% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
34 securitiesTop 10 holdings make up 55.4% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 9.75% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 8.96% |
| Piramal Pharma Ltd | Pharmaceuticals & Biotechnology | Small Cap | 6.36% |
| Rubicon Research Ltd | Pharmaceuticals & Biotechnology | Small Cap | 6.08% |
| Aurobindo Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 6.03% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 5.51% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.78% |
| Emcure Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Small Cap | 4.03% |
| Laurus Labs Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 3.91% |
| Neuland Laboratories Ltd | Pharmaceuticals & Biotechnology | Small Cap | 3.82% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹405 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹392 Cr
Exit load, stamp duty & tax
27-Dec-24
1% on or before 3M, Nil after 3M
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Objective Of The Scheme Is To Generate Long Term Capital Appreciation By Predominantly Investing In Equity And Equity Related Securities Of Pharma, Healthcare And Allied Companies.
Fund house
Bajaj Finserv Asset Management Limited
Frequently asked questions
What is the NAV of Bajaj Finserv Healthcare Fund - Direct - Growth?
The NAV of Bajaj Finserv Healthcare Fund - Direct - Growth is ₹11.16 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Bajaj Finserv Healthcare Fund - Direct - Growth?
The expense ratio charged by Bajaj Finserv Healthcare Fund - Direct - Growth is 0.9%.
What is the Min. SIP of Bajaj Finserv Healthcare Fund - Direct - Growth?
The minimum SIP investment in Bajaj Finserv Healthcare Fund - Direct - Growth is ₹500 per month.
What is the Min. Lumpsum of Bajaj Finserv Healthcare Fund - Direct - Growth?
The minimum lumpsum investment in Bajaj Finserv Healthcare Fund - Direct - Growth is ₹500.
What is the Exit Load of Bajaj Finserv Healthcare Fund - Direct - Growth?
The exit load for Bajaj Finserv Healthcare Fund - Direct - Growth is: 1% on or before 3M, Nil after 3M
.svg){kind=small}